Sort
17,828 grants matching “crispr”
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$478,329Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$478,329Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Shared Resource: Genomics & Bioinformatics
$478,302Jeffrey Delrow · Fred Hutchinson Cancer Center · P30 · FY2024 · CA
Shared Resource: Genomics & Bioinformatics
$478,300Jeffrey Delrow · Fred Hutchinson Cancer Center · P30 · FY2023 · CA
Shared Resource: Genomics & Bioinformatics
$478,300Matthew Fitzgibbon · Fred Hutchinson Cancer Center · P30 · FY2022 · CA
Dissection and Rescue of Mechanical and Transcriptional Defects in Desmoplakin Cardiomyopathy
$478,298Adam S Helms · University Of Michigan At Ann Arbor · R56 · FY2021 · HL
Mechanisms of cell-autonomous plasma membrane stabilization and repair in plants
$478,269Shunyuan Xiao · Univ Of Maryland, College Park · R35 · FY2025 · GM
APOL1 Nephropathy: Linking Genetics and Mechanisms
$478,239David J Friedman · Beth Israel Deaconess Medical Center · R01 · FY2023 · MD
APOL1 Nephropathy: Linking Genetics and Mechanisms
$478,239David J Friedman · Beth Israel Deaconess Medical Center · R01 · FY2021 · MD
APOL1 Nephropathy: Linking Genetics and Mechanisms
$478,239David J Friedman · Beth Israel Deaconess Medical Center · R01 · FY2020 · MD
APOL1 Nephropathy: Linking Genetics and Mechanisms
$478,239David J Friedman · Beth Israel Deaconess Medical Center · R01 · FY2022 · MD
Mechanisms of progression of vascular malformation to lymphangiosarcoma
$478,232Jun-Lin Guan · University Of Cincinnati · R01 · FY2024 · HL
Function and application of lung surfactant proteins
$478,144Tom A Rapoport · Harvard Medical School · R01 · FY2020 · HL
Deciphering mechanisms of transcriptional repression which drive midline glioma
$478,129Richard E Phillips · University Of Pennsylvania · R01 · FY2025 · CA
Metabolic determinants of barrier function in rifampin-sensitive and -resistant Mtb
$478,125Kyu Y Rhee · Brigham And Women'S Hospital · U19 · FY2023 · AI
Developing a novel therapeutic strategy for overcoming TKI resistance in ALL
$478,090Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Project 1: Novel mechanisms driving mucin secretion and mucus plugging in type 2-high asthma
$478,006David J Erle · University Of California, San Francisco · U19 · FY2023 · AI
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer
$477,962Charles Nicholson Landen · University Of Virginia · R01 · FY2022 · CA
Novel Genome Editing for the Treatment of Glaucoma
$477,939Val C Sheffield · University Of Iowa · R01 · FY2020 · EY
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
$477,848Teresa Davoli · New York University School Of Medicine · R37 · FY2025 · CA
Deciphering pathways involved in topoisomerase II turnover
$477,818Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Ubiquitin-mediated proteolysis and cell cycle control
$477,801Jeffrey Wade Harper · Harvard Medical School · R01 · FY2019 · AG
Predicting causal non-coding variants in a founder population
$477,647Stephen Montgomery · Stanford University · R01 · FY2015 · HG
Off target mechanisms of kinase inhibitor toxicities
$477,614Navjot Pabla · Ohio State University · R01 · FY2024 · DK
High-risk hepatoblastoma dissemination control by oncogenic NRF2
$477,530Sarah Elizabeth Woodfield · Baylor College Of Medicine · R01 · FY2025 · CA